Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

Scientists at the University of Warwick have developed a fully fibre-coupled terahertz (THz) imaging system that ...

Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key ...

Ibex Medical Analytics has signed a strategic partnership with HNL Lab Medicine to deploy clinical-grade AI for prostate ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM) ("PAVmed"), today ...

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2025 Earnings Call Transcript March 26, 2026 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07.

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second ...

Pacific Fusion has opened up its pulsed-power Demonstration System to external researchers to run experiments on its high-energy platform.

Neurophet partners with US-based Alzheimer's network on imaging AI. South Korean company Neurophet has signed a memorandum of ...

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the full ...

General Fusion Inc. (“General Fusion” or the “Company”), a leader in the global race to commercialize fusion energy, today announced a new peer-reviewed publication in the scientific journal Fusion ...

No matter the size or severity, wounds on human skin are difficult to monitor while they heal. Biopsies disrupt the wound ...